Bloomberg Talks podcast

Eli Lilly CFO Lucas Montarce Talks Weight Loss Pill, Business Outlook

0:00
9:08
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

See omnystudio.com/listener for privacy information.

Altri episodi di "Bloomberg Talks"